Figure 2. Generation of DAG-based molecular subtypes. (A) Location of DAG in chromosome. (B) Analysis of correlation and prognostic value of DAG in LUAD. (C) Clinical survival prognosis curve. (D) Unsupervised PCA of LUAD samples in DAG-based molecular subtypes. (E) Relationship of DAG expression and clinical variables (survival status, age, stage and gender) in DAG-based molecular subtypes.